COVID-19 vaccine maker BioNTech inks research deal with Australia
COVID-19 vaccine maker BioNTech inks research deal with Australia
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
COVID-19 vaccine maker BioNTech inks research deal with Australia
Recurring global deadly disease outbreaks crippling economies
Saline nasal washes helpful in flushing out Covid-19 virus
HT team October 5, 2022: More than 500 global health workers across WHO’s six regions are meeting in Armenia to reflect on lessons.
HT team As the Covid-19 pandemic torments the world, scientists in the US have made a drug that brings the virus’s downfall. Chemicals.
Pfizer acquires app that can detect Covid-19 through cough sound
HQ team 23 September 2022: The global threat of COVID-19 is far from over as the rollout of medical countermeasures stagnates, a UN.
Covid-19 may result in the emergence of more “dangerous” variants that can be challenging to control, according to the WHO. The pandemic, which.
Mixing and matching of Covid-19 vaccines is a “dangerous” trend as there is no sufficient backup data available to support its efficacy, the.
uly 13, 2021: About a tenth of the local population, or 811 million people, were undernourished during the pandemic year, 2020, according to.